Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Legal Opinion of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Meeting materials of the 2024 Fourth Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the intention to change independent directors and adjust the members of the board special committee
Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders in 2024
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on progress in providing guarantees for wholly-owned subsidiaries
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on progress in providing guarantees for wholly-owned subsidiaries
Zhenbao Island: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Zhenbao Island: Legal Opinion of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Legal Opinion of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Meeting materials of the 2024 Third Extraordinary General Meeting of Shareholders of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the branch obtaining a notice of approval for the marketing application of chemical raw materials
Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on adding guarantee amounts for wholly-owned subsidiaries
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the extension of some fund-raising investment projects
An indicative announcement by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the adjustment of the exchange price of non-public exchangeable corporate bonds issued by the controlling shareholder
Heilongjiang ZBD Pharmaceutical Co., Ltd. Announcement on Receiving Notice of Non-Approval of Pharmaceutical Listing Application
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s legal opinion for the second extraordinary shareholders' meeting in 2024
No Data